Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 4
2006 2
2007 1
2008 1
2009 2
2010 3
2011 1
2012 2
2013 2
2014 6
2015 11
2016 12
2017 13
2018 14
2019 12
2020 10
2021 6
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Assessment of food effects during clinical development.
Vinarov Z, Butler J, Kesisoglou F, Koziolek M, Augustijns P. Vinarov Z, et al. Among authors: kesisoglou f. Int J Pharm. 2023 Mar 25;635:122758. doi: 10.1016/j.ijpharm.2023.122758. Epub 2023 Feb 18. Int J Pharm. 2023. PMID: 36801481 Review.
Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network.
Vinarov Z, Abrahamsson B, Artursson P, Batchelor H, Berben P, Bernkop-Schnürch A, Butler J, Ceulemans J, Davies N, Dupont D, Flaten GE, Fotaki N, Griffin BT, Jannin V, Keemink J, Kesisoglou F, Koziolek M, Kuentz M, Mackie A, Meléndez-Martínez AJ, McAllister M, Müllertz A, O'Driscoll CM, Parrott N, Paszkowska J, Pavek P, Porter CJH, Reppas C, Stillhart C, Sugano K, Toader E, Valentová K, Vertzoni M, De Wildt SN, Wilson CG, Augustijns P. Vinarov Z, et al. Among authors: kesisoglou f. Adv Drug Deliv Rev. 2021 Apr;171:289-331. doi: 10.1016/j.addr.2021.02.001. Epub 2021 Feb 18. Adv Drug Deliv Rev. 2021. PMID: 33610694 Free article. Review.
Industry's View on Using Quality Control, Biorelevant, and Clinically Relevant Dissolution Tests for Pharmaceutical Development, Registration, and Commercialization.
Grady H, Elder D, Webster GK, Mao Y, Lin Y, Flanagan T, Mann J, Blanchard A, Cohen MJ, Lin J, Kesisoglou F, Hermans A, Abend A, Zhang L, Curran D. Grady H, et al. Among authors: kesisoglou f. J Pharm Sci. 2018 Jan;107(1):34-41. doi: 10.1016/j.xphs.2017.10.019. Epub 2017 Oct 24. J Pharm Sci. 2018. PMID: 29074376 Review.
Regulatory utility of physiologically-based pharmacokinetic modeling to support alternative bioequivalence approaches and risk assessment: A workshop summary report.
Wu F, Mousa Y, Raines K, Bode C, Tsang YC, Cristofoletti R, Zhang H, Heimbach T, Fang L, Kesisoglou F, Mitra A, Polli J, Kim MJ, Fan J, Zolnik BS, Sun D, Zhang Y, Zhao L. Wu F, et al. Among authors: kesisoglou f. CPT Pharmacometrics Syst Pharmacol. 2023 May;12(5):585-597. doi: 10.1002/psp4.12907. Epub 2023 Jan 4. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 36530026 Free PMC article. Review.
In Vitro Biopredictive Methods: A Workshop Summary Report.
Pepin XJH, Dressman J, Parrott N, Delvadia P, Mitra A, Zhang X, Babiskin A, Kolhatkar V, Seo P, Taylor LS, Sjögren E, Butler JM, Kostewicz E, Tannergren C, Koziolek M, Kesisoglou F, Dallmann A, Zhao Y, Suarez-Sharp S. Pepin XJH, et al. Among authors: kesisoglou f. J Pharm Sci. 2021 Feb;110(2):567-583. doi: 10.1016/j.xphs.2020.09.021. Epub 2020 Sep 19. J Pharm Sci. 2021. PMID: 32956678
A survey on IVIVC/IVIVR development in the pharmaceutical industry - Past experience and current perspectives.
Nguyen MA, Flanagan T, Brewster M, Kesisoglou F, Beato S, Biewenga J, Crison J, Holm R, Li R, Mannaert E, McAllister M, Mueller-Zsigmondy M, Muenster U, Ojala K, Page S, Parr A, Rossenu S, Timmins P, Van Peer A, Vermeulen A, Langguth P. Nguyen MA, et al. Among authors: kesisoglou f. Eur J Pharm Sci. 2017 May 1;102:1-13. doi: 10.1016/j.ejps.2017.02.029. Epub 2017 Feb 21. Eur J Pharm Sci. 2017. PMID: 28235611 Review.
92 results